Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.
Horvath A, Rainer F, Bashir M, Leber B, Schmerboeck B, Klymiuk I, Groselj-Strele A, Durdevic M, Freedberg DE, Abrams JA, Fickert P, Stiegler P, Stadlbauer V.
Horvath A, et al. Among authors: groselj strele a.
Sci Rep. 2019 Aug 19;9(1):12000. doi: 10.1038/s41598-019-48352-5.
Sci Rep. 2019.
PMID: 31427714
Free PMC article.